In the first quarter of fiscal 2025, HOLX is expected to have benefited from expanding breast health offerings.

In the first quarter of fiscal 2025, HOLX is expected to have benefited from the strength of its core franchises.

Shares of Hologic Inc. HOLX shed 1.35% to $71.77 Tuesday, on what proved to be an all-around favorable trading session for ...

This was the stock's second consecutive day of gains.

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $71.02 which represents a slight increase of $0.32 or 0.45% from the prior close of $70.7. The stock opened at $70.45 and touched a low ...

Investment analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for shares of Hologic in a research note issued on ...

The Hologic Women’s Health Index’s 2023 data found a decrease in testing for any cancer among women — a first in the survey’s ...

Hologic Inc (HOLX) stock saw a decline, ending the day at $70.7 which represents a decrease of $-0.49 or -0.69% from the prior close of $71.19. The stock opened at $71.42 and touched a low of $69.87 ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

The most recent trading session ended with Hologic (HOLX) standing at $71.77, reflecting a -1.35% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

Paragon 28 (FNA – Research Report) received a Hold rating and price target from Needham analyst Michael Matson today. The company’s shares ...

Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...